India to Sri Lanka: Syringe Export Trade Route

The India to Sri Lanka Syringe corridor is one of India's established pharmaceutical export routes, with 31 shipments documented worth a combined $4.4M USD. The route is dominated by GLAND PHARMA LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's syringe manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $141.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 70% of all shipments, consistent with syringe's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 28 days port-to-port. The route has recorded an annual growth rate of 22.4%, placing it at rank #3 among India's top syringe export destinations globally.

On the import side, key buyers of Indian syringe in Sri Lanka include State Pharmaceuticals Corporation, PEOPLE'S BANK, SOFTCARE INTERNATIONAL(PVT)LTD and 12 others. State Pharmaceuticals Corporation is the single largest importer with 4 shipments valued at $2.0M USD.

India's syringe exports to Sri Lanka are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LIMITED with 5 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in Sri Lanka benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLAND PHARMA LIMITED, BRAWN LABORATORIES LIMITED, JODAS EXPOIM PRIVATE LIMITED — together account for 95% of total trade value on this route. The average shipment value of $141.4K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as low molecular weightheparin enoxaparin sodium injection usp 60mg in 0 6mlpre filled syringe and low molecular weightheparin enoxaparinsodium injection usp 60mg in 0 6mlpre filled syringe, suggesting that buyers in Sri Lanka tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, State Pharmaceuticals Corporation is the largest importer with 4 shipments worth $2.0M USD — representing 45% of all syringe imports from India on this route. A total of 15 buyers are active on this corridor.